23 biotech investors in Texas
We list 23 biotech investors in Texas as of November 2026: each has an SEC filing on file, and the list was last checked on 6 Nov 2026. The cities with the most head offices on this list are Austin (14), Houston (5) and Dallas (2).
Top 5 biotech investors in Texas, ranked by recent fund activity
Among firms with a published profile and a dated fund or deal in the last 24 months. The rule: Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stated focus on the US (15: full marks when the firm names the US as where it invests, half when it says global), size of the fund on file on a log scale (15) and completeness of the public record (10). Regional focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns. The same rule orders the whole list; it is repeated in the method box.
Gore Range Capital
Type: VC firm · HQ: Southlake, TX · Stages: Seed · Focus: Biotech, Healthtech, Medtech · Latest activity: New deal, Aug 2026 · Fund size on file: $250M (SEC Form D, 2026)
Dated new deal in Aug 2026; $250M fund on file (SEC Form D, 2026); states biotech and life sciences as a focus; names the US as where it invests; 1 named decision-maker on file.
8VC
Type: VC firm · HQ: Austin, TX · Focus: Biotech, Data, AI, Healthtech · Latest activity: New deal, Oct 2026 · Fund size on file: $400M (SEC Form D, 2026)
Dated new deal in Oct 2026; $400M fund on file (SEC Form D, 2026); 13% of its observed portfolio is biotech and life sciences; names the US as where it invests; 8 named decision-makers on file.
Transpose Platform
Type: VC firm · HQ: Houston, TX · Stages: Pre-seed · Focus: Biotech, AI, Generalist · Latest activity: New fund, Sep 2026 · Fund size on file: $500M (SEC Form D, 2026)
Latest fund filing dated Sep 2026; $500M fund on file (SEC Form D, 2026); states biotech and life sciences as a focus; 8 named decision-makers on file.
JSTAR Capital
Type: VC firm · HQ: Austin, TX · Stages: Growth · Focus: Biotech, Healthtech, AI, Fintech · Latest activity: New fund, Aug 2026 · Fund size on file: $100M (SEC Form D, 2025)
Latest fund filing dated Aug 2026; $100M fund on file (SEC Form D, 2025); 25% of its observed portfolio is biotech and life sciences; 8 named decision-makers on file.
SHD Partners
Type: VC firm · HQ: Dallas, TX · Stages: Seed, Series A · Focus: Biotech, Healthtech, Medtech · Latest activity: Portfolio news, Nov 2026 · Private fund assets: $61M (SEC Form ADV)
Portfolio news dated Nov 2026; $61M on file (SEC Form ADV); 29% of its observed portfolio is biotech and life sciences; 6 named decision-makers on file.
First 11 of 23 biotech investors in Texas
| Investor | Type | HQ | Stagesour research | Focusour research | Latest fund or deal | Fund sizeas filed or stated | Checked | Contacts |
|---|---|---|---|---|---|---|---|---|
| Gore Range Capital | VC firm | Southlake, TX | Seed | Biotech, Healthtech, Medtech | New deal, Aug 2026 | $250M (SEC Form D, 2026) | 4 Nov 2026 | 1 name, firm email · Unlock |
| 8VC | VC firm | Austin, TX | Biotech, Data, AI, Healthtech | New deal, Oct 2026 | $400M (SEC Form D, 2026) | 4 Nov 2026 | 8 names · Unlock | |
| Transpose Platform | VC firm | Houston, TX | Pre-seed | Biotech, AI, Generalist | New fund, Sep 2026 | $500M (SEC Form D, 2026) | 4 Nov 2026 | 8 names · Unlock |
| JSTAR Capital | VC firm | Austin, TX | Growth | Biotech, Healthtech, AI, Fintech | New fund, Aug 2026 | $100M (SEC Form D, 2025) | 4 Nov 2026 | 8 names · Unlock |
| SHD Partners | VC firm | Dallas, TX | Seed, Series A | Biotech, Healthtech, Medtech | Portfolio news, Nov 2026 | $61M (SEC Form ADV) | 5 Nov 2026 | 6 names, firm email · Unlock |
| Audere | VC firm | Austin, TX | Growth | Biotech, Cybersecurity, AI, Robotics | New fund, Oct 2026 | $100M (SEC Form D, 2024) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Hyve Ventures | VC firm | Austin, TX | Pre-seed | Biotech, Consumer, Healthtech, Logistics | New fund, Nov 2026 | $6M (SEC Form D, 2025) | 4 Nov 2026 | 1 name · Unlock |
| Monograph Capital | VC firm | Fort Worth, TX | Pre-seed | Biotech, Healthtech | New deal, Jun 2026 | $326M (SEC Form ADV) | 5 Nov 2026 | 8 names, firm email · Unlock |
| First Bight Ventures | VC firm | Houston, TX | Seed, Series A | Biotech, Climate Tech, Healthtech, Industrial Tech | New fund, Mar 2026 | $80M (SEC Form D, 2022) | 4 Nov 2026 | 5 names · Unlock |
| Humain Ventures | VC firm | Austin, TX | Pre-seed, Seed | Biotech, Healthtech, AI, Edtech | New fund, May 2026 | $10M (SEC Form D, 2024) | 4 Nov 2026 | 1 name · Unlock |
| Next Ventures | VC firm | Austin, TX | Seed | Biotech, Healthtech, AI, Medtech | New fund, Dec 2024 | $100M (SEC Form D, 2024) | 5 Nov 2026 | 8 names · Unlock |
You are seeing 11 of 23. The full list adds 12 more investors and 123 named decision-makers.
One-time payment. No subscription. No account.
Or get the free sample.
How these 23 break down
By metro area
| Metro area | On this list | Share |
|---|---|---|
| Austin | 14 | 61% |
| Houston | 5 | 22% |
| Dallas-Fort Worth | 4 | 17% |
By city
| City | On this list | Share |
|---|---|---|
| Austin | 14 | 61% |
| Houston | 5 | 22% |
| Dallas | 2 | 9% |
By stage
| Stage | On this list | Share |
|---|---|---|
| Pre-Seed | 7 | 30% |
| Seed | 13 | 57% |
| Series A | 4 | 17% |
| Growth | 3 | 13% |
Stage is our research. A firm can back more than one stage.
Method and limits
- Source
- All 23 rows carry an SEC filing (Form D or Form ADV). All 23 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule
- Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states biotech and life sciences as a focus on its own site, or we observed it in the firm's portfolio. Place: head office in Texas.
- Order
- Firms with a published profile come first. Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stated focus on the US (15: full marks when the firm names the US as where it invests, half when it says global), size of the fund on file on a log scale (15) and completeness of the public record (10). Regional focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns.
- Last refreshed
- November 2026. Rows on this list were checked between 4 Nov 2026 and 6 Nov 2026.
- Fill rates
- Of 23 rows: stage 19, sector 23, fund size 22, website 23. In the paid file: named decision-makers on 22 rows, firm email on 8, LinkedIn page on 15, check size on 1.
- Corrections
- Email hello@theinvestordatabase.com or use the update form. We act within 5 working days.
Questions
How many biotech investors in Texas are there?
We list 23 as of November 2026. 17 of the 23 have a fund filing or a dated deal in the last 12 months. The cities with the most are Austin (14), Houston (5) and Dallas (2).
Which biotech investors in Texas raised a new fund in the last 12 months?
14 of the 23 have a fund filing dated in the last 12 months. The most recent on this list are Hyve Ventures (Nov 2026), Audere (Oct 2026) and Transpose Platform (Sep 2026).
What is the typical fund size of biotech investors in Texas?
The median fund size on file for this list is $50M, across the 19 firms with a size on an SEC Form D. The fund on file is each firm's main fund, which is not always its newest. The other 4 do not disclose a size there.
How do I contact biotech investors in Texas?
The paid file holds 123 named decision-makers across 22 of these 23 and a firm email for 8. We publish the address a firm lists itself, never a personal email. Each free row links to a profile with the firm's website.
Where does the data on biotech investors in Texas come from?
All 23 rows have an SEC filing on file (Form D or Form ADV). Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 6 Nov 2026 at the latest. The whole file is re-verified twice a year.
Related lists
Biotech investors in California (108)AI investors in Texas (56)SaaS investors in Texas (47)Healthtech investors in Texas (42)Biotech investors in Massachusetts (37)Biotech investors in New York (29)Fintech investors in Texas (27)Medtech investors in Texas (25)Defense tech investors in Texas (20)Biotech investors in Florida (15)Deep tech investors in Texas (15)Consumer investors in Texas (15)
Not sure this is the right list? Describe your raise in the investor matching tool and get a shortlist. The link opens it set to biotech and life sciences and Texas. Guide: new venture funds and capital raised by state. Markdown version of this page.
Check the quality first
A free sample of 100 investors, every column, with sources and dates.